Case Studies

Real data validates technological transformation, benchmark cases build trust

Benchmark AIDP-X Platform

First AI-led drug completes Phase II clinical milestone globally

18 Months

IPF candidate drug from target discovery to clinical filing

$2.6M

Only 5% of traditional path cost

95%

95% cost reduction, less than 5% of traditional path

22.3%

Rentosertib Phase II clinical FVC improvement rate (p<0.01)

Early Discovery2-3 Case Studies

Preclinical3-5 Case Studies

Clinical1-2 Case Studies

Commercial2-3 Case Studies

Benchmark AIDP-X Platform8-13 Case Studies

Early Discovery~6 Months

Preclinical~12 Months

Clinical~12 Months

CommercialFirst AI-led drug completes Phase II clinical milestone globally

Benchmark AIDP-X Platform18 Months

Traditional R&D Cost

$50M+

AI-Driven Cost

$2.6M

95% cost reduction, less than 5% of traditional path

Traditional R&D Model100%

AI-Driven Model5%

47%

Real data validates technological transformation, benchmark cases build trust

Leading Pharma Enterprise Survey Data

62%

Real data validates technological transformation, benchmark cases build trust

Leading Pharma Enterprise Survey Data

40%

Real data validates technological transformation, benchmark cases build trust

Leading Pharma Enterprise Survey Data

Get exclusive AI transformation plan and ROI analysis